Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Fever between 37 to 39 degrees; headache; pain in eyes; body pain; chills; body strengthless; no appetite; pain in arm; cough; chest pain; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient received first dose of BNT162B2 (COMIRNATY), via an unspecified route of administration, administered in right arm on 02Jun2021 09:00 (at the age of 46-year-old) as single dose for covid-19 immunisation. Medical history included kidney stone. Concomitant medications included influenza A(H1N1) pdm09 vaccine taken for H1N1 influenza immunisation on 15May2021 and nitrofurantoin. On 03Jun2021 at 20:00, the patient experienced fever between 37 to 39 degrees, headache, pain in eyes, body pain, chills, body strengthless, no appetite, pain in arm, cough, chest pain. Seriousness Criteria for events was disability or permanent damage. No treatment was received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was not pregnant. The outcome of the events was not recovered. Information on the lot/batch number has been requested.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166